NO981814D0 - Nye heterocykliske forbindelser, fremgangsmÕte ved deres fremstilling og farmas÷ytiske sammensetninger som inneholder dem - Google Patents

Nye heterocykliske forbindelser, fremgangsmÕte ved deres fremstilling og farmas÷ytiske sammensetninger som inneholder dem

Info

Publication number
NO981814D0
NO981814D0 NO981814A NO981814A NO981814D0 NO 981814 D0 NO981814 D0 NO 981814D0 NO 981814 A NO981814 A NO 981814A NO 981814 A NO981814 A NO 981814A NO 981814 D0 NO981814 D0 NO 981814D0
Authority
NO
Norway
Prior art keywords
alkyl
cycloalkyl
aryl
optionally substituted
preparation
Prior art date
Application number
NO981814A
Other languages
English (en)
Other versions
NO981814L (no
NO317742B1 (no
Inventor
Gurald Guillaumet
Isabelle Charton
Ahmed Mamai
Pierre Renard
Bruno Pfeiffer
Philippe Delagrange
Buatrice Guardiola
Original Assignee
Adir
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Adir filed Critical Adir
Publication of NO981814D0 publication Critical patent/NO981814D0/no
Publication of NO981814L publication Critical patent/NO981814L/no
Publication of NO317742B1 publication Critical patent/NO317742B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D335/00—Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom
    • C07D335/04—Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D335/06—Benzothiopyrans; Hydrogenated benzothiopyrans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/58—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
    • C07D311/64—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4 with oxygen atoms directly attached in position 8
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D319/00—Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D319/10—1,4-Dioxanes; Hydrogenated 1,4-dioxanes
    • C07D319/14—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems
    • C07D319/16—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D319/18—Ethylenedioxybenzenes, not substituted on the hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D327/00—Heterocyclic compounds containing rings having oxygen and sulfur atoms as the only ring hetero atoms
    • C07D327/02—Heterocyclic compounds containing rings having oxygen and sulfur atoms as the only ring hetero atoms one oxygen atom and one sulfur atom
    • C07D327/06—Six-membered rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Psychiatry (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Anesthesiology (AREA)
  • Cardiology (AREA)
  • Pain & Pain Management (AREA)
  • Child & Adolescent Psychology (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Pyrane Compounds (AREA)
  • Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
NO19981814A 1997-04-25 1998-04-22 Nye heterocykliske forbindelser, fremgangsmate ved deres fremstilling ogfarmasoytiske sammensetninger som inneholder dem, samt anvendelse av forbindelsene for fremstilling av et medikament NO317742B1 (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9705110A FR2762598A1 (fr) 1997-04-25 1997-04-25 Nouveaux composes heterocycliques, leur procede de preparation et les compositions pharmaceutiques qui les contiennnent

Publications (3)

Publication Number Publication Date
NO981814D0 true NO981814D0 (no) 1998-04-22
NO981814L NO981814L (no) 1998-10-26
NO317742B1 NO317742B1 (no) 2004-12-13

Family

ID=9506306

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19981814A NO317742B1 (no) 1997-04-25 1998-04-22 Nye heterocykliske forbindelser, fremgangsmate ved deres fremstilling ogfarmasoytiske sammensetninger som inneholder dem, samt anvendelse av forbindelsene for fremstilling av et medikament

Country Status (19)

Country Link
US (1) US5919814A (no)
EP (1) EP0873993B1 (no)
JP (1) JP4125418B2 (no)
CN (1) CN1145622C (no)
AT (1) ATE213496T1 (no)
AU (1) AU736716B2 (no)
BR (1) BR9801448B1 (no)
CA (1) CA2235421C (no)
DE (1) DE69803894T2 (no)
DK (1) DK0873993T3 (no)
ES (1) ES2173556T3 (no)
FR (1) FR2762598A1 (no)
HK (1) HK1014956A1 (no)
HU (1) HU223468B1 (no)
NO (1) NO317742B1 (no)
NZ (1) NZ330279A (no)
PL (1) PL198572B1 (no)
PT (1) PT873993E (no)
ZA (1) ZA983490B (no)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19548708A1 (de) * 1995-12-23 1997-06-26 Merck Patent Gmbh Cyclische Sulfone
FR2799757B1 (fr) * 1999-10-15 2001-12-14 Adir Nouveaux derives polycycliques azaindoliques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
FR2805993B1 (fr) * 2000-03-08 2004-01-16 Adir Utilisation de ligands melatoninergiques pour l'obtention de compositions pharmaceutiques destinees a la prevention ou au traitement du developpement de la tolerance aux composes nitres
JP2004511501A (ja) * 2000-10-19 2004-04-15 メルク　エンド　カムパニー　インコーポレーテッド エストロゲン受容体モジュレーター
US6750213B2 (en) 2000-10-19 2004-06-15 Merck & Co., Inc. Estrogen receptor modulators
US7449526B2 (en) * 2001-10-04 2008-11-11 Supresta U.S. Llc Oligomeric, hydroxy-terminated phosphonates
DE60334202D1 (de) 2002-04-24 2010-10-28 Merck Sharp & Dohme Modulatoren des östrogenrezeptors
FR2918370B1 (fr) * 2007-07-02 2009-08-28 Servier Lab Nouveaux derives naphtaleniques,leur procede de preparation et les compositions pharmaceutiques qui les contiennent
FR2918372B1 (fr) * 2007-07-02 2009-08-28 Servier Lab Nouveaux derives naphtaleniques,leur procede de preparation et les compositions pharmaceutiques qui les contiennent

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3737195A1 (de) * 1987-11-03 1989-05-18 Bayer Ag Chromanderivate, verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln
FR2691149B1 (fr) * 1992-05-18 1994-07-08 Adir Nouveaux composes thiochromaniques, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent.
FR2716680B1 (fr) * 1994-02-25 1996-04-05 Adir Nouveaux dérivés de benzodioxane, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent.

Also Published As

Publication number Publication date
DE69803894T2 (de) 2002-11-07
ZA983490B (en) 1998-10-29
JP4125418B2 (ja) 2008-07-30
HUP9800964A3 (en) 2000-06-28
PL325989A1 (en) 1998-10-26
HUP9800964A2 (hu) 2000-05-28
NZ330279A (en) 1998-11-25
AU736716B2 (en) 2001-08-02
NO981814L (no) 1998-10-26
CA2235421A1 (fr) 1998-10-25
CN1145622C (zh) 2004-04-14
FR2762598A1 (fr) 1998-10-30
EP0873993B1 (fr) 2002-02-20
ES2173556T3 (es) 2002-10-16
EP0873993A1 (fr) 1998-10-28
ATE213496T1 (de) 2002-03-15
HK1014956A1 (en) 1999-10-08
AU6359198A (en) 1998-10-29
PT873993E (pt) 2002-07-31
BR9801448A (pt) 2000-02-08
US5919814A (en) 1999-07-06
HU9800964D0 (en) 1998-06-29
CN1197797A (zh) 1998-11-04
NO317742B1 (no) 2004-12-13
HU223468B1 (hu) 2004-07-28
DE69803894D1 (de) 2002-03-28
DK0873993T3 (da) 2002-06-10
CA2235421C (fr) 2003-09-16
BR9801448B1 (pt) 2009-01-13
JPH10298178A (ja) 1998-11-10
PL198572B1 (pl) 2008-06-30

Similar Documents

Publication Publication Date Title
MX9301986A (es) Derivados de perhidroisoindol, procedimiento para su preparacion y composiciones farmaceuticas que los contienen.
ES2195382T3 (es) Compuestos indolcarboxilicos y su uso como compuestos farmaceuticos.
DK0662471T3 (da) Naphthalenderivater med affinitet over for melatonin-receptorer, fremgangsmåde til deres fremstilling og farmaceutiske samm
NO981814D0 (no) Nye heterocykliske forbindelser, fremgangsmÕte ved deres fremstilling og farmas÷ytiske sammensetninger som inneholder dem
NO982921D0 (no) Nye kromenforbindelser, en fremgangsmÕte for deres fremstilling og farmas°ytiske sammensetninger som inneholder disse
NO962207L (no) Nye alkoksyarylforbindelser, fremgangsmåte ved deres fremstilling og farmasöytiske sammensetninger inneholdende dem
TW333532B (en) Benzopyrans
NO305751B1 (no) Substituerte benzensulfonylurinstoffer og -tiourinstoffer, deres anvendelse for fremstilling av medikament eller diagnostikum, sÕvel som legemidler inneholdende forbindelsene
NO961456D0 (no) Nye tricykliske amider, fremgangsmåter ved deres fremstilling og farmasöytiske sammensetninger som inneholder dem
DK0606175T3 (da) 2-cyan-3-hydroxypropenamider, fremgangsmåde til deres fremstilling, deres anvendelse som lægemidler samt farmaceutiske præparater med indhold deraf
DK406587A (da) 1,4-dihydropyridinderivater, fremgangsmaade til fremstilling deraf samt farmaceutiske praeparater indeholdende disse
DK161250C (da) Analogifremgangsmaade til fremstilling af 4-aroyl-imidazol-2-oner eller pharmaceutisk acceptable salte deraf
ZA88208B (en) Sweetening agents derived from guanidinoacetic and ethanamidinoacetic acids,process for sweetening various products,and compositions containing such sweetening agents
SE7908439L (sv) Nya beta-laktonderivat av 2-hydroxicyklopentankarboxylsyra, sett for framstellning och anvendning derav som lekemedel samt farmaceutiska kompositioner innehallande dessa foreningar
DK283189D0 (da) Phenothiazinderivater, deres fremstilling og farmaceutiske praeparater deraf
ATE122352T1 (de) 3-(3-ethyl-1,2,4-oxadiazol-5-yl)-1- azabicycloheptan, verfahren zu seiner herstellung und dieses enthaltende pharmazeutische zubereitungen.
DK0532725T3 (da) Isoxazolderivater som lysfilterpræparater
NO976101L (no) Nye ellipticinforbindelser, en fremgangsmÕte ved deres fremstilling, samt farmas°ytiske blandinger som inneholder dem